Bio-Techne
TECH
#1708
Rank
C$14.12 B
Marketcap
$89.32
Share price
0.85%
Change (1 day)
-11.54%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$0.85 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are C$0.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30C$0.89 B16.42%
2022-06-30C$0.76 B-10.78%
2021-06-30C$0.85 B-2.86%
2020-06-30C$0.88 B-6.44%
2019-06-30C$0.94 B39.55%
2018-06-30C$0.67 B-14.5%
2017-06-30C$0.79 B144.24%
2016-06-30C$0.32 B20.52%
2015-06-30C$0.26 B274.65%
2014-06-30C$71.69 M68.06%
2013-06-30C$42.66 M-6.64%
2012-06-30C$45.69 M49.74%
2011-06-30C$30.51 M68.71%
2010-06-30C$18.08 M0.28%
2009-06-30C$18.03 M-12.56%
2008-06-30C$20.62 M13.2%
2007-06-30C$18.22 M-45.8%
2006-06-30C$33.62 M0.22%
2005-06-30C$33.54 M-10.25%
2004-06-30C$37.37 M4.09%
2003-06-30C$35.91 M-25.34%
2002-06-30C$48.09 M-16.15%
2001-06-30C$57.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$68.92 B 7,949.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.04 B 372.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$42.61 B 4,877.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$40.49 B 4,628.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.96 B 362.92%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$149.82 B 17,397.79%๐Ÿ‡บ๐Ÿ‡ธ USA
C$39.97 M-95.33%๐Ÿ‡บ๐Ÿ‡ธ USA